CRWV Research Update — September 23, 2026
Updated Thesis
CoreWeave operates a specialized GPU cloud platform purpose-built for generative AI workloads, offering high-performance GPU and CPU compute, storage, networking, and managed services to large enterprises from bare-metal and virtual server options. The business is growing explosively, with revenue up 112.3% year over year in the most recent quarter and a TTM gross margin of 67.4%, but it is doing so at enormous cost: TTM operating margin is -3.0%, TTM net margin is -25.4%, ROE is -45.4%, and free cash flow per share is -$24.78 as capital spending vastly outpaces operating cash flow. The stock trades at $86.76 against a blended fair value estimate of $125.80, implying roughly 45% upside, and analyst consensus is Buy with a $136.67 average target, about 57.5% above the current price.
The investment grade as of this refresh is B — solid business quality. B-tier business, A-tier valuation versus blended fair value with 45% upside.
Grade Change
In this research cycle, the investment grade for CoreWeave, Inc. Class A Common Stock moved from C to B. B-tier business, A-tier valuation versus blended fair value with 45% upside.
Key Metrics at a Glance
- Revenue growth: +112.3% year over year
- Net margin: -25.4%
- Fair value upside: +45.0% to our estimate of $126
Current price: $86.76
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. CoreWeave, Inc. Class A Common Stock remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full CRWV research →](/stocks/CRWV)